Insider Transactions in Q1 2026 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2026
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
418
-0.25%
|
$2,508
$6.15 P/Share
|